To exclude the possibility that 46,XY DSD of patients 1 and 2 resulted from a genetic or genomic abnormality other than the MAP3K1 variant, we performed whole exome sequencing and array-based comparative genomic hybridization (CGH) analysis. The gene discussed is MAP3K1; the disease is disorder of sexual differentiation.